Tuesday, February 11, 2025

Vaxxas secures $2M grant from BARDA to develop needle-free mRNA vaccines

Vaxxas, a clinical-stage biotechnology company specializing in high-density microarray patch (HD-MAP) vaccine delivery, has been awarded a $2 million (AUD 3.2 million) grant as a Concept Stage winner in the United States Biomedical Advanced Research and Development Authority’s (BARDA) $50 million Patch Forward Prize. 

Industry assistance falls to $15B: Productivity Commission’s 50th review

The Productivity Commission has unveiled its 50th annual Trade and Assistance Review (TAR), detailing the amount of industry assistance provided by the Australian Government for the 2022-23 fiscal year.

Moderna announces new head of mRNA vaccine manufacturing site in Melbourne

Global medical technology company Moderna has appointed Emma Harrington as the inaugural manufacturing site head for the company’s new mRNA vaccine manufacturing site in Australia. 

Moderna’s vaccine manufacturing hub in Victoria nears completion ahead of schedule

Victoria is one step closer to locally manufacturing mRNA vaccines and medicines, with the construction of Moderna’s mRNA vaccine manufacturing facility reaching the halfway mark, progressing faster than originally planned.

Queensland’s employment forecasted to grow significantly by 2025-26

The Anticipating Future Skills Series from Jobs Queensland has released four headline employment forecasts for the five-year period 2025-26, estimating total employment of nearly three million, an increase of 207,000 new jobs.

Australia’s 4.6% decline in labour productivity driven by pandemic, low unemployment rate

The Productivity Commission’s 2023 Bulletin has revealed that the 4.6 per cent fall in labour productivity for the 12 months to March 2023 is brought about by the unwinding of COVID-19-related effects and historically low unemployment rate.

Subscribe to our newsletter

Keep me up to date with the latest Australian Manufacturing news, events, resources, and information.